| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Reproductive Biology Unit (M.L., J.L., B.K.T.), Department of Obstetrics and Gynaecology and Department of Physiology, University of Ottawa, Ottawa Civic Hospital Loeb Research Institute, Ottawa, Ontario, Canada K1Y 4E9; Program in Developmental Biology and Division of Gastroenterology (P.A.H., T.T., J.L.W.), Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8; and Department of Anatomy and Cell Biology (L.A.), University of Toronto, Toronto, Ontario, Canada M5S 1A8
Address all correspondence and requests for reprints to: Dr. Benjamin K. Tsang, Department of Obstetrics and Gynaecology, Ottawa Civic Hospital, 1053 Carling Avenue, Ottawa, Ontario, Canada K1Y 4E9. E-mail: ben{at}civich.ottawa.on.ca
Although mothers against dpp (MAD) and its related proteins (MADR) are believed to be important components of the cell signaling pathway for the transforming growth factor ß (TGFß) superfamily, the presence and regulation of these signaling molecules in ovarian cells by TGFß is not known. In the present studies, we have examined the presence of MADR2 and MADR1, two members of the MADR family, in hen granulosa cells at different stages of follicular development. The influence of TGFß in vitro on their expression was assessed, particularly in the context of TGFß-induced down-regulation of cytosolic phospholipase A2 (cPLA2), a key enzyme in the biosynthesis of eicosanoids. We have demonstrated for the first time the presence of MADR2 and MADR1 in hen granulosa cells at different stages of follicular development. The expression of MADR2, but not of MADR1, was up-regulated by TGFß in vitro in a concentration- and time-dependent manner. Granulosa cell MADR2 expression was maximal during early stages of follicular development, when the granulosa cell cPLA2 system is most responsive to the growth factor. The changes in MADR2 expression were accompanied by reciprocal alterations in the expression of cPLA2. These findings are consistent with the hypothesis that homologous up-regulation of MADR2 in granulosa cells may be an important determinant in its follicular stage-specific responsiveness to TGFß and possibly in the suppression of cPLA2 gene transcription by the growth factor.
This article has been cited by other articles:
![]() |
H. Wang, J.-Y. Jiang, C. Zhu, C. Peng, and B. K. Tsang Role and Regulation of Nodal/Activin Receptor-Like Kinase 7 Signaling Pathway in the Control of Ovarian Follicular Atresia Mol. Endocrinol., October 1, 2006; 20(10): 2469 - 2482. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.L. Johnson, J.T. Bridgham, and D.C. Woods Cellular Mechanisms and Modulation of Activin A- and Transforming Growth Factor {beta}-Mediated Differentiation in Cultured Hen Granulosa Cells Biol Reprod, December 1, 2004; 71(6): 1844 - 1851. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gueripel, M. Benahmed, and A. Gougeon Sequential Gonadotropin Treatment of Immature Mice Leads to Amplification of Transforming Growth Factor {beta} Action, Via Upregulation of Receptor-Type 1, Smad 2 and 4, and Downregulation of Smad 6 Biol Reprod, March 1, 2004; 70(3): 640 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Drummond, M. T. Le, J.-F. Ethier, M. Dyson, and J. K. Findlay Expression and Localization of Activin Receptors, Smads, and {beta}glycan to the Postnatal Rat Ovary Endocrinology, April 1, 2002; 143(4): 1423 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ostendorf, U. Kunter, C. van Roeyen, S. Dooley, N. Janjic, J. Ruckman, F. Eitner, and J. Floege The Effects of Platelet-Derived Growth Factor Antagonism in Experimental Glomerulonephritis Are Independent of the Transforming Growth Factor-{beta} System J. Am. Soc. Nephrol., March 1, 2002; 13(3): 658 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Pekary, J. M. Hershman, and L. Berg Tumor Necrosis Factor, Ceramide, Transforming Growth Factor-{beta}1, and Aging Reduce Na+/I- Symporter Messenger Ribonucleic Acid Levels in FRTL-5 Cells Endocrinology, February 1, 1998; 139(2): 703 - 712. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |